HLscience Co. Ltd Market Cap ($19.88 Million)

$19.88 Million USD · ₩29.34 Billion KRW · Rank #24988

Market Cap & Net Worth: HLscience Co. Ltd (239610)

HLscience Co. Ltd market cap. HLscience Co. Ltd (KQ:239610) has a market capitalization of $19.88 Million (₩29.34 Billion) as of November 6, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24988 globally and #1823 in its home market, demonstrating a 8.68% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying HLscience Co. Ltd's stock price ₩5760.00 by its total outstanding shares 5092951 (5.09 Million). Also see 239610 cash flow metrics for how efficiently the company converts equity into cash flow.

HLscience Co. Ltd Market Cap History (2016–2026)

HLscience Co. Ltd market cap history from 2016 to 2026. Data shows change from $88.84 Million to $19.88 Million (-16.27% CAGR). Check 239610 live share price for real-time trading data and today's change.

Index Memberships

HLscience Co. Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$207.23 Billion	0.01%	#962 of 1384
Kosdaq Composite Index KQ11	$207.23 Billion	0.01%	#962 of 1384

Weight: HLscience Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

HLscience Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how HLscience Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of HLscience Co. Ltd to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.00x

HLscience Co. Ltd's market cap is 0.00 times its annual revenue

Industry average: 0.59x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$88.84 Million	$40.93 Billion	$6.07 Billion	0.00x	0.01x
2017	$102.91 Million	$40.20 Billion	$4.94 Billion	0.00x	0.02x
2018	$134.74 Million	$64.11 Billion	$10.86 Billion	0.00x	0.01x
2019	$172.28 Million	$128.26 Billion	$19.74 Billion	0.00x	0.01x
2020	$149.97 Million	$143.04 Billion	$19.64 Billion	0.00x	0.01x
2021	$120.46 Million	$104.38 Billion	$13.54 Billion	0.00x	0.01x
2022	$64.20 Million	$52.76 Billion	$1.59 Billion	0.00x	0.04x
2023	$55.02 Million	$25.59 Billion	-$1.38 Billion	0.00x	N/A
2024	$42.59 Million	$17.66 Billion	-$7.88 Billion	0.00x	N/A

Competitor Companies of 239610 by Market Capitalization

Companies near HLscience Co. Ltd in the global market cap rankings as of November 6, 2026. Also see 239610 asset base for a full breakdown of the balance sheet.

Key companies related to HLscience Co. Ltd by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#514	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#538	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$47.80
#588	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.79 Billion	CN¥49.05
#621	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of HLscience Co. Ltd (2016–2026)

Market capitalization of HLscience Co. Ltd from 2016 to today. Between 2016 and today, HLscience Co. Ltd's market cap moved from $88.84 Million to $ 19.88 Million, with a yearly change of -16.27%.

Year	Market Cap	Change (%)
2026	₩19.88 Million	-28.80%
2025	₩27.92 Million	-34.44%
2024	₩42.59 Million	-22.58%
2023	₩55.02 Million	-14.30%
2022	₩64.20 Million	-46.71%
2021	₩120.46 Million	-19.68%
2020	₩149.97 Million	-12.95%
2019	₩172.28 Million	+27.86%
2018	₩134.74 Million	+30.93%
2017	₩102.91 Million	+15.84%
2016	₩88.84 Million	--

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of HLscience Co. Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$19.88 Million USD
MoneyControl	$19.88 Million USD
MarketWatch	$19.88 Million USD
marketcap.company	$19.88 Million USD
Reuters	$19.88 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$19.88 Million

₩29.34 Billion KRW

Market Cap Rank

#24988 Global

#1823 in Korea

Share Price

₩5760.00

Change (1 day)

-3.36%

52-Week Range

₩5090.00 - ₩9180.00

All Time High

₩105342.87